august 24 2025 glp-1 drugs have taken the world by storm, helping many people lose 11%–16% of their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't 2025 ADA Highlights: A New

Expand Your Laboratory Knowledge Explore Frontier Peptide Labs educational resources covering BPC-157 research, TB-500 research, research peptide blends, peptide combination research, peptide purity testing, HPLC analysis, LC-MS verification, laboratory handling, storage recommendations, analytical chemistry, peptide quality control, and scientific peptide research

With the power of GLP-1 medication, we empower our patients to take control of their weight and embrace a healthier, more vibrant lifestyle

For years, glucagon-like peptide-1 receptor agonists were only available as injectables such as semaglutide and dulaglutide

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

Inform your doctor about all supplements you are taking

Step into the vanguard of dental restoration with GP Implants' Hex Connection